Clinical trial
Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA…
NCT00458835 · Covis Pharma S.à.r.l., Industry · Completed
Key facts
| NCT number | NCT00458835 |
|---|---|
| Title | Comparison Between Systemic Exposure to Ciclesonide Nasal Spray, Ciclesonide HFA Nasal Aerosol and Orally Inhaled Ciclesonide (BY9010/M1-422) |
| Official title | A Randomized, Open-label, Single-dose, 3-period Crossover, Pharmacokinetic Study Designed to Compare the Systemic Des-ciclesonide Exposure of OMNARIS™ (Ciclesonide) Nasal Spray, Ciclesonide HFA Nasal Aerosol, and Orally Inhaled Ciclesonide |
| Lead sponsor | Covis Pharma S.à.r.l., Industry |
| Status | Completed |
| Phase | Phase 4 |
| Study type | Interventional |
| Conditions | Allergic Rhinitis |
| Intervention type | Drug |
| Interventions | Ciclesonide |
| Enrollment | 30 |
| Start date | Apr 1, 2007 |
| Primary completion | Apr 1, 2008 |
| Completion | Apr 1, 2008 |
| First posted | Apr 11, 2007 |
| Last update posted | Feb 9, 2023 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: